Tag | Content |
---|
EnhancerAtlas ID | HS127-15771 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr19:50096700-50097500 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NFYA | MA0060.3 | chr19:50096828-50096839 | TCTGATTGGTT | - | 6.62 | NFYA | MA0060.3 | chr19:50097159-50097170 | TCTGATTGGTT | - | 6.62 | NFYB | MA0502.1 | chr19:50097229-50097244 | CTGATTGGCTCCTTC | - | 6.38 | NR2C2 | MA0504.1 | chr19:50097214-50097229 | TGACCCTTGACCCTC | - | 6.42 | Nr2f6 | MA0677.1 | chr19:50097214-50097228 | TGACCCTTGACCCT | - | 6.77 | RREB1 | MA0073.1 | chr19:50096977-50096997 | CCCCAACCCACCCCAATTCT | + | 6.09 | Rxra | MA0512.2 | chr19:50097214-50097228 | TGACCCTTGACCCT | - | 6.87 | ZNF263 | MA0528.1 | chr19:50097239-50097260 | CCTTCCCTTTTTCCCTCCCCA | - | 6.01 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_68954 | chr19:50093383-50097450 | H9 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GGCCCCCATC CCGCCCCGCT TTGGGCTGGC CCTCCCCCTC CCCCCGAGGC AGCTGATTGG 60 CTGTTGAAAG TTCCGCCCCT CCTAATTGGC CGTGGCCCGT GCCGTGGCCC GCCCCTTGCT 120 GTGTCTCCTC TGATTGGTTG CCTTTGAGGC TGCTGGTCGC TGCTTCATTT CTCGCCGGAT 180 TCGTCCGCCC CTGCCTCGCC CCTCCCCTTT CGCTCCAATT GGCCCTGTTA CCATCAGCCC 240 CCAAATCCCA CCTTCTCTTC CAGGCTTTTC CGCCTCTCCC CAACCCACCC CAATTCTTTC 300 CCTCTGGGTT TGCCCTATTC TTTTGGCTCT TTGGAACTCT GAATTCTTTC TTCCTGATTC 360 CCTTTCTTCC TGATTGGCTC TAATTCTCTG GCCCGCCCTG TTTTATCTTA TTTTGCCCCA 420 TTGCCTTATT CTACCCACCT TGCCTTTGCC TCCAAGGTTT CTGATTGGTT CCCTCTTCCT 480 AGGGGTACTG GTAATGACAT GATGCTGTCC AGTTTGACCC TTGACCCTCC TGATTGGCTC 540 CTTCCCTTTT TCCCTCCCCA TCTTTTTTTC TGAACCCTCC CACTTAGCTC AATCCTTTCT 600 GACACGTTCT CTGGTCTTTC TTAGACTTCA TTGTCCCATC CTTTCCTCTT CCTTGCTGGA 660 AATATCCAAA TTTGGTCTCC CTCCCAGCCT TACTGAGGAC TCTGTTCTTT TGCTCCTGGC 720 TCTTTCGCTT CTAGATTTTT CTACACTTTT GTCTACCATT TCCTACCTGG GCCCCCTGTC 780 CTTATGACTG GATTGCCCCT 800
|